Our team.
Cura Communications has assembled an exceptional, multidisciplinary team with first-hand, multi-market experience in the psychedelics and mental health communications and public relations. Interested in shaping the future of psychedelic medicine? Please Reach out.
Chris Koddermann
- Founder and Managing Director
- [email protected]
- +41 (79) 434 25 78
As a passionate consumer of books, I am constantly on the hunt for a good story. Stories are the thing that give shape to our lives. The stories of where we come from. Those in which we play a role. The ones that inspire, teach, thrill, and fascinate us. And of course, those we tell ourselves and others.
The story of psychedelics is one that captured my attention at an early age and has played an increasing central role in my own over the last several years. Having spent over two decades working as a communications and public affairs professional, first in politics and then in senior corporate roles, I now have the great fortune of leveraging my wealth of experience to support our clients as they help write the next chapter in the story of psychedelics. But my interest in not merely a professional one. As co-founder and chair of the board of the International Therapeutic Psilocybin Rescheduling Initiative, an international coalition pursuing a rescheduling of psilocybin under the 1971 Convention on Psychotropic Substances, I am deeply passionate about the enterprise of advancing the development of psychedelic medicines as treatment options for patients in need.
CURA Communications was founded on the belief that it takes a team of people who understand the story of psychedelics in order to serve the companies, non-profits and other organizations that are central to determining their future course. Please drop me a line if you’d like to learn more about how we can help tell your story.
Chris Koddermann
Founder and Managing Director
[email protected]
+41 (79) 434 25 78
As a passionate consumer of books, I am constantly on the hunt for a good story. Stories are the thing that give shape to our lives. The stories of where we come from. Those in which we play a role. The ones that inspire, teach, thrill, and fascinate us. And of course, those we tell ourselves and others.
The story of psychedelics is one that captured my attention at an early age and has played an increasing central role in my own over the last several years. Having spent over two decades working as a communications and public affairs professional, first in politics and then in senior corporate roles, I now have the great fortune of leveraging my wealth of experience to support our clients as they help write the next chapter in the story of psychedelics. But my interest in not merely a professional one. As co-founder and chair of the board of the International Therapeutic Psilocybin Rescheduling Initiative, an international coalition pursuing a rescheduling of psilocybin under the 1971 Convention on Psychotropic Substances, I am deeply passionate about the enterprise of advancing the development of psychedelic medicines as treatment options for patients in need.
CURA Communications was founded on the belief that it takes a team of people who understand the story of psychedelics in order to serve the companies, non-profits and other organizations that are central to determining their future course. Please drop me a line if you’d like to learn more about how we can help tell your story.
Camilla Dormer
- Director & UK Lead
- [email protected]
As a former Vice President of Communications at atai Life Sciences, Camilla has served on the front lines of one of the industry largest players’ efforts to navigate the challenges of psychedelics and mental health communications and public relations. Playing a pivotal in its repositioning from ‘psychedelics start-up’ to established and leading mental health company, Camilla led atai’s post-IPO communications with lead responsibility for communications strategy and content, corporate brand and reputation management, investor and financial communications, social media, executive positioning and internal communications
With twenty plus years of pharmaceutical and healthcare sector experience, including as Director of Global Communications at GSK and senior leadership roles with public relations agencies, Camilla brings a depth of multidisciplinary expertise to her work at Cura Communications.
Camilla Dormer
Director & UK Lead
[email protected]
As a former Vice President of Communications at atai Life Sciences, Camilla has served on the front lines of one of the industry largest players’ efforts to navigate the challenges of psychedelics and mental health communications and public relations. Playing a pivotal in its repositioning from ‘psychedelics start-up’ to established and leading mental health company, Camilla led atai’s post-IPO communications with lead responsibility for communications strategy and content, corporate brand and reputation management, investor and financial communications, social media, executive positioning and internal communications
With twenty plus years of pharmaceutical and healthcare sector experience, including as Director of Global Communications at GSK and senior leadership roles with public relations agencies, Camilla brings a depth of multidisciplinary expertise to her work at Cura Communications.
Jim Mandler
- US Lead
- [email protected]
A veteran communications and media relations professional with decades of health care sector experience, Jim has been responsible for driving coverage of some of the biggest psychedelics and mental health stories of the last decade. As Senior Director of Media Relations for NYU Langone Health and NYU’s Center for Psychedelic Medicine, Jim was generating media interest in the work of some of field’s leading researchers while the psychedelic renaissance was still its infancy.
Prior to joining NYU in 2014, Jim served as Vice President Public Affairs and Communications at Continuum Health Partners and as Vice President Communications at Beth Israel Medical Center.
A former journalist, Jim brings a deep understanding of the U.S. media landscape, an ability to translate research into news and a passion for the written word to his work at Cura Communications.
Jim Mandler
US Lead
[email protected]
A veteran communications and media relations professional with decades of health care sector experience, Jim has been responsible for driving coverage of some of the biggest psychedelics and mental health stories of the last decade. As Senior Director of Media Relations for NYU Langone Health and NYU’s Center for Psychedelic Medicine, Jim was generating media interest in the work of some of field’s leading researchers while the psychedelic renaissance was still its infancy.
Prior to joining NYU in 2014, Jim served as Vice President Public Affairs and Communications at Continuum Health Partners and as Vice President Communications at Beth Israel Medical Center.
A former journalist, Jim brings a deep understanding of the U.S. media landscape, an ability to translate research into news and a passion for the written word to his work at Cura Communications.
May Lee
- Director, Growth and Partnerships
- [email protected]
A communications and marketing professional with a background in mental health, May has been active in the psychedelics and mental health industry from its nascency. The first employee of psychedelics company Numinus, May led the establishment of its communications and marketing function where she spearheaded its pre-IPO strategy spanning corporate brand, marketing communications, executive positioning, media relations, investor and financial communications and social media.
Especially committed to helping founders, executives and KOLs develop thought leadership and personal brands that reflect social impact and sustainability, May is an active advocate for equitable healthcare, diversity & inclusion and psychedelics education.
A proud supporter of psychedelic non-profits, May serves as an advisor to Heroic Hearts Project Canada and the Psychedelic Medicine Association.
May Lee
Director, Growth and Partnerships
[email protected]
A communications and marketing professional with a background in mental health, May has been active in the psychedelics and mental health industry from its nascency. The first employee of psychedelics company Numinus, May led the establishment of its communications and marketing function where she spearheaded its pre-IPO strategy spanning corporate brand, marketing communications, executive positioning, media relations, investor and financial communications and social media.
Especially committed to helping founders, executives and KOLs develop thought leadership and personal brands that reflect social impact and sustainability, May is an active advocate for equitable healthcare, diversity & inclusion and psychedelics education.
A proud supporter of psychedelic non-profits, May serves as an advisor to Heroic Hearts Project Canada and the Psychedelic Medicine Association.
Ryan Furby
- Director
- [email protected]
An international corporate communications professional, Ryan has over 25 years’ experience in protecting and building the reputations of some of the world’s most admired brands. His expertise includes corporate branding and messaging, media relations, crisis communications and digital/social media engagement for companies in highly regulated and dynamic industries.
Previously, Ryan was Director and Global Head of Corporate and Internal Communications at Biogen, one of the world’s first biotechnology giants. While there, he advised 21 country affiliates on communications strategies for various product launches, safety issues, regulatory approvals and pricing negotiations.
Ryan is the recipient of the PRSA Silver Anvil, PR News CSR Award, Silver Sabre, PRSA Big Apple Award and other industry awards.
Ryan Furby
- Director
- [email protected]
An international corporate communications professional, Ryan has over 25 years’ experience in protecting and building the reputations of some of the world’s most admired brands. His expertise includes corporate branding and messaging, media relations, crisis communications and digital/social media engagement for companies in highly regulated and dynamic industries.
Previously, Ryan was Director and Global Head of Corporate and Internal Communications at Biogen, one of the world’s first biotechnology giants. While there, he advised 21 country affiliates on communications strategies for various product launches, safety issues, regulatory approvals and pricing negotiations.
Ryan is the recipient of the PRSA Silver Anvil, PR News CSR Award, Silver Sabre, PRSA Big Apple Award and other industry awards.
Jonas Bodin
- Creative Director & Brand Strategist
- [email protected]
CURA Communications‘ Colorado-based Creative Director and Brand Strategist, Jonas has spent much of the last twenty years crafting award-winning earned media campaigns for some of the world’s leading brands, including Audi, AirBnB and Electrolux. With experience spanning pharmaceuticals and biotechnology, health care, tech, automotive, hospitality and consumer goods, Jonas deploys his talents as a writer, creative thinker and storyteller to build, grow and manage brand and corporate reputation through high earned-attention media strategies.
Having started his career in media relations and serving in a number of other communications and public relations roles, Jonas brings a multidisciplinary approach and understanding to the table at CURA Communications.
Jonas Bodin
Creative Director & Brand Strategist
[email protected]
CURA Communications‘ Colorado-based Creative Director and Brand Strategist, Jonas has spent much of the last twenty years crafting award-winning earned media campaigns for some of the world’s leading brands, including Audi, AirBnB and Electrolux. With experience spanning pharmaceuticals and biotechnology, health care, tech, automotive, hospitality and consumer goods, Jonas deploys his talents as a writer, creative thinker and storyteller to build, grow and manage brand and corporate reputation through high earned-attention media strategies.
Having started his career in media relations and serving in a number of other communications and public relations roles, Jonas brings a multidisciplinary approach and understanding to the table at CURA Communications.
Adam Hussain
- Intern
- [email protected]
Currently studying Political Science at Stanford University, Adam is passionate about the psychedelic industry, specifically the law and policy surrounding various medicines and therapies. A former intern at the Psychedelic Medicine Coalition, where he contributed to social media and marketing, he has a strong grasp of the US psychedelic environment.
Adam is also an active participant in US politics and has a background in grassroots organizing and campaign finance, including marketing and event planning for Congressional campaigns and I AM A TEEN VOTER, a youth-initiated movement for civic engagement.
Adam Hussain
- Intern
- [email protected]
Currently studying Political Science at Stanford University, Adam is passionate about the psychedelic industry, specifically the law and policy surrounding various medicines and therapies. A former intern at the Psychedelic Medicine Coalition, where he contributed to social media and marketing, he has a strong grasp of the US psychedelic environment.
Adam is also an active participant in US politics and has a background in grassroots organizing and campaign finance, including marketing and event planning for Congressional campaigns and I AM A TEEN VOTER, a youth-initiated movement for civic engagement.